Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment StrategiesSteven P. Treon, Jorge J. Castillo, Andrew R. Branagan et al.|Journal of Clinical Oncology|2020Cited by 165
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström MacroglobulinemiaSteven P. Treon, Jorge J. Castillo, Kirsten Meid et al.|Journal of Clinical Oncology|2020Cited by 150
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemiaJorge J. Castillo, Steven P. Treon, Kirsten Meid et al.|Leukemia|2021Cited by 82
Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm TrialAndrew R. Branagan, Madhav V. Dhodapkar, Eamon Duffy et al.|Clinical Lymphoma Myeloma & Leukemia|2017Cited by 48
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasiasAndrew R. Branagan, Madhav V. Dhodapkar, Eamon Duffy et al.|Blood Advances|2021Cited by 21